Related Experiment Video

Updated: Aug 17, 2026

Identification of Kinase-substrate Pairs Using High Throughput Screening
11:13

Identification of Kinase-substrate Pairs Using High Throughput Screening

Published on: August 29, 2015

Oncogenic RET receptors display different autophosphorylation sites and substrate binding specificities

X Liu1, Q C Vega, R A Decker

  • 1Department of Biological Chemistry, University of Michigan School of Medicine, Ann Arbor, 48109, USA.

The Journal of Biological Chemistry
|March 8, 1996
PubMed

Insights

The RET receptor tyrosine kinase is crucial for development and linked to MEN2B. MEN2B mutations alter RET autophosphorylation, affecting signaling and potentially causing a more aggressive disease phenotype.

Area of Science:

  • Molecular biology
  • Oncology
  • Developmental biology

Background:

  • The c-ret proto-oncogene encodes a receptor tyrosine kinase vital for neural crest and kidney development.
  • Germline mutations in RET are implicated in multiple endocrine neoplasia (MEN) 2A/2B, familial medullary thyroid carcinoma (FMTC), and Hirschsprung's disease.
  • The precise signal transduction mechanisms of RET, particularly in disease states, remain largely unelucidated.

Purpose of the Study:

  • To investigate the autophosphorylation patterns of wild-type RET and MEN mutants.
  • To elucidate the molecular mechanisms underlying RET-associated diseases.
  • To understand how RET mutations impact receptor signaling capabilities.

Main Methods:

  • Site-directed mutagenesis was employed to create RET mutants.
  • Phosphopeptide mapping was utilized to analyze autophosphorylation sites.
  • Analysis focused on wild-type RET and MEN2B mutant variants.

Main Results:

  • Six autophosphorylation sites were identified in wild-type RET.
  • The MEN2B RET mutant exhibited a lack of phosphorylation at Tyr-1096.
  • This MEN2B mutation also created a novel phosphorylation site and reduced Grb2 binding.

Conclusions:

  • Altered autophosphorylation patterns in the MEN2B RET mutant suggest a mechanism for its aggressive phenotype.
  • Changes in RET phosphorylation impact its signaling capabilities.
  • Understanding these alterations is key to deciphering RET-driven disease pathogenesis.

More Related Videos

Oligopeptide Competition Assay for Phosphorylation Site Determination09:16

Oligopeptide Competition Assay for Phosphorylation Site Determination

Published on: May 18, 2017

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

Related Concept Videos

Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include: